The accumulation of CEACAM1+ Tregs correlates with tumor progression; notably, their depletion enhances tumor-infiltrating lymphocyte (TIL) function and potentiates the therapeutic efficacy of anti-programmed death-1 (PD-1) therapy (44). Here, CEACAM1 is linked to neoplasm.